| Select | PubMed ID | Description |
| 10651777 | Clin Exp Allergy. 2000 Feb;30(2):242-54.
Phleum pratense-specific T cells of allergic rhinitis patients display a broader
recognition pattern than phleum pratense-specific serum immunoglobulin E.
Van Neerven RJ(1), Arnved J, Ipsen H.
|
| 11307030 | Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):406-10.
The influence of CpG motifs on a protein or DNA-based Th2-type immune response
against major pollen allergens Bet v 1a, Phl p 2 and Escherichia coli-derived
beta-galactosidase.
Hochreiter R(1), Hartl A, Freund J, Valenta R, Ferreira F, Thalhamer J.
|
| 12154002 | FASEB J. 2002 Aug;16(10):1301-3. Epub 2002 Jun 21.
Combination vaccines for the treatment of grass pollen allergy consisting of
genetically engineered hybrid molecules with increased immunogenicity.
Linhart B(1), Jahn-Schmid B, Verdino P, Keller W, Ebner C, Kraft D, Valenta R.
|
| 25441634 | J Allergy Clin Immunol. 2015 May;135(5):1207-7.e1-11. doi:
1016/j.jaci.2014.09.012. Epub 2014 Nov 13.
Development and characterization of a recombinant, hypoallergenic, peptide-based
vaccine for grass pollen allergy.
Focke-Tejkl M(1), Weber M(1), Niespodziana K(1), Neubauer A(2), Huber H(2),
Henning R(2), Stegfellner G(2), Maderegger B(2), Hauer M(2), Stolz F(2),
Niederberger V(3), Marth K(1), Eckl-Dorna J(3), Weiss R(4), Thalhamer J(4), Blatt
K(5), Valent P(5), Valenta R(6).
|
